Piramal Pharma Ltd — Quarterly Results & Earnings

₹136.54

+1.77%

Profit Growth YoY-539.22%Latest quarter

Sales Growth YoY-8.83%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-539.22%

🔴 Significant decline

YoY Sales Growth-8.83%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

15.15%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

1.52

ROE

1.11%

ROCE

6.45%

💡

Growth Analysis

Piramal Pharma Ltd reported YoY profit growth of -539.22% and revenue growth of -8.83% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Piramal Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.